電腦輔助診斷(CAD) 市場規模、佔有率和成長分析：按產品類型、成像方式、應用、部署模式、最終用戶和地區分類 - 行業預測，2026-2033 年

2024 年全球電腦輔助診斷(CAD) 市場價值為 9.5 億美元，預計到 2025 年將成長至 10.035 億美元，到 2033 年將成長至 15.1209 億美元，在預測期（2026-2033 年）內複合年成長率為 5.3%。

全球電腦輔助診斷(CAD) 市場主要受診斷影像需求成長和人工智慧快速發展所驅動，這兩項技術均提高了放射科醫生的工作效率和診斷準確性。該市場涵蓋旨在識別醫學影像中可疑觀察的軟體工具，幫助臨床醫生更早、更準確地做出診斷，從而降低治療成本並改善患者預後。該領域正從簡單的基於規則的系統發展到複雜的深度學習演算法，監管部門的批准和創新的報銷模式促進了其應用，從而推動了其成長。醫院將這些人工智慧驅動的工具整合到工作流程中，將加快對嚴重病症的識別，從而縮短治療時間。這種整合將帶來永續的收入，促進持續的調查，並使全球服務不足的地區和特殊篩檢活動受益。

全球電腦輔助診斷(CAD) 市場促進因素

醫療專業人員和患者對早期疾病檢測益處的認知不斷提高，正推動醫療機構在其診療實踐中採用電腦輔助診斷(CAD) 解決方案。這項轉變旨在最佳化診斷流程，最大限度地減少診斷不確定性，並強調預防醫學。人們認知到 CAD 技術能夠改善臨床決策支援、提高工作流程效率以及增強影像解讀的一致性等優勢，這進一步加速了其應用。醫院和影像中心渴望投資這些解決方案，以提高服務品質和改善病患預後，最終提升市場接受度，並促進產業內的持續創新和應用。

全球電腦輔助診斷（CAD）市場的限制因素

各地區複雜多元的監理核准流程對電腦輔助診斷(CAD) 系統的廣泛商業性應用構成重大挑戰。開發商必須投入大量資源以滿足一系列證據、檢驗和文件標準，導致產品上市時間延長，開發成本飆升。這種情況阻礙了小規模創新者的積極性，也使得全球產品上市和統一的報銷策略難以發展。因此，儘管技術不斷進步，但這些因素共同阻礙了商業化進程，限制了特定地區醫療機構的用藥管道，並抑制了整體市場成長。

全球電腦輔助診斷(CAD) 市場趨勢

全球電腦輔助診斷(CAD) 市場正經歷著向人工智慧驅動的診斷準確性提升的顯著轉變。這一趨勢的特點是整合先進的機器學習模型，以提高檢測靈敏度，同時最大限度地減少不同影像模式下解讀結果的差異。供應商優先考慮模型的可解釋性，建立臨床檢驗夥伴關係，並推動持續學習，從而增強臨床醫生的信心，並促進其順利融入日常實踐。這一趨勢有助於早期且一致地識別異常情況。此外，市場也關注個人化的診斷路徑和多學科決策，從而改善病灶特徵分析和觀察優先排序。最終，這將從獨立工具發展成為能夠提高臨床醫生效率和信心的協作式臨床支援系統。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球電腦輔助診斷(CAD) 市場規模：依產品類型分類

• 軟體
• 硬體
• 服務

全球電腦輔助診斷(CAD) 市場規模：以成像方式分類

• 乳房X光攝影
• 電腦斷層掃描（CT）
• 磁振造影（MRI）
• 超音波
• X光影像
• 其他

全球電腦輔助診斷(CAD) 市場規模：按應用領域分類

• 乳癌檢測
• 肺癌檢測
• 結腸癌檢測
• 神經系統疾病的檢測
• 心血管疾病檢測
• 其他

全球電腦輔助診斷(CAD) 市場規模：依部署模式分類

• 現場
• 基於雲端的

全球電腦輔助診斷(CAD) 市場規模：依最終使用者分類

• 醫院
• 診斷影像中心
• 專科診所
• 學術研究機構
• 其他

全球電腦輔助診斷(CAD) 市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• iCAD, Inc.
• GE HealthCare Technologies Inc.
• Siemens Healthineers AG
• Philips Healthcare
• Canon Medical Systems Corporation
• Fujifilm Holdings Corporation
• Hologic, Inc.
• Riverain Technologies
• ScreenPoint Medical BV
• Aidoc Medical Ltd.
• Lunit Inc.
• Qure.ai Technologies Pvt. Ltd.
• Zebra Medical Vision Ltd.
• ContextVision AB
• Imagen Technologies, Inc.
• Vuno Inc.
• Oxipit UAB
• Infervision Medical Technology Co., Ltd.
• Arterys Inc.
• RadNet, Inc.

結論與建議

Global Computer Aided Detection Market size was valued at USD 950.0 Million in 2024 and is poised to grow from USD 1000.35 Million in 2025 to USD 1512.09 Million by 2033, growing at a CAGR of 5.3% during the forecast period (2026-2033).

The global computer-aided detection market is significantly driven by the increasing demand for diagnostic imaging paired with rapid advancements in artificial intelligence, enhancing both radiologist efficiency and diagnostic accuracy. This market encompasses software tools designed to identify suspicious findings in medical images, aiding clinicians in making earlier and more precise diagnoses, which can lower treatment costs and enhance patient outcomes. The sector has evolved from simple rule-based systems to advanced deep learning algorithms, with growth fueled by regulatory approvals and innovative reimbursement models that incentivize adoption. As hospitals incorporate these AI-driven tools into their workflows, they expedite the identification of critical conditions, thereby improving treatment timelines. This integration fosters sustainable revenue, promotes ongoing research, and extends benefits to underserved regions and specialized screening initiatives globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Computer Aided Detection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Computer Aided Detection Market Segments Analysis

Global computer aided detection market is segmented by product type, imaging modality, application, deployment mode, end user and region. Based on product type, the market is segmented into Software, Hardware and Services. Based on imaging modality, the market is segmented into Mammography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, X-ray Imaging and Others. Based on application, the market is segmented into Breast Cancer Detection, Lung Cancer Detection, Colorectal Cancer Detection, Neurological Disorder Detection, Cardiovascular Disease Detection and Others. Based on deployment mode, the market is segmented into On-Premises and Cloud-Based. Based on end user, the market is segmented into Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Academic & Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Computer Aided Detection Market

The growing awareness among healthcare professionals and patients regarding the advantages of early disease detection is encouraging healthcare providers to integrate computer-aided detection solutions into their practices. This shift aims to enhance diagnostic processes, minimize uncertainty in diagnoses, and emphasize preventive care. The perceived benefits of improved clinical decision support, increased workflow efficiency, and more consistent image interpretation further drive the adoption of these technologies. Hospitals and imaging centers are motivated to invest in such solutions to elevate service quality and improve patient outcomes, ultimately fostering greater market acceptance and stimulating ongoing innovation and implementation within the industry.

Restraints in the Global Computer Aided Detection Market

The intricate and diverse regulatory approval processes in various regions pose considerable challenges for the broad commercial adoption of computer-aided detection systems. Developers are required to invest substantial resources to meet a range of evidentiary, validation, and documentation standards, leading to extended timeframes for market entry and heightened development costs. This scenario disheartens smaller innovators and complicates global product launches, as well as the establishment of consistent reimbursement strategies. Consequently, these factors collectively hinder commercialization efforts, restrict healthcare providers' access in certain areas, and impede the overall growth of the market, despite the technological advancements available.

Market Trends of the Global Computer Aided Detection Market

The Global Computer Aided Detection market is witnessing a significant shift towards AI-driven diagnostic precision, characterized by the integration of advanced machine learning models that enhance detection sensitivity while minimizing interpretive variability across various imaging modalities. This trend is leading to earlier and more consistent identification of abnormalities, as vendors prioritize model explainability, establish clinical validation partnerships, and promote continuous learning to foster clinician trust and facilitate smoother integration into routine practices. Additionally, the focus is on personalized diagnostic pathways and multidisciplinary decision-making, which enhances lesion characterization and prioritizes findings, ultimately transitioning from standalone tools to collaborative clinical support systems that boost clinician efficiency and confidence.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Computer Aided Detection Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Software
• Hardware
• Services

Global Computer Aided Detection Market Size by Imaging Modality & CAGR (2026-2033)

• Market Overview
• Mammography
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound
• X-ray Imaging
• Others

Global Computer Aided Detection Market Size by Application & CAGR (2026-2033)

• Market Overview
• Breast Cancer Detection
• Lung Cancer Detection
• Colorectal Cancer Detection
• Neurological Disorder Detection
• Cardiovascular Disease Detection
• Others

Global Computer Aided Detection Market Size by Deployment Mode & CAGR (2026-2033)

• Market Overview
• On-Premises
• Cloud-Based

Global Computer Aided Detection Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics
• Academic & Research Institutes
• Others

Global Computer Aided Detection Market Size & CAGR (2026-2033)

• North America (Product Type, Imaging Modality, Application, Deployment Mode, End User)
  • US
  • Canada
• Europe (Product Type, Imaging Modality, Application, Deployment Mode, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Imaging Modality, Application, Deployment Mode, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Imaging Modality, Application, Deployment Mode, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Imaging Modality, Application, Deployment Mode, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• iCAD, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Riverain Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScreenPoint Medical BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aidoc Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lunit Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qure.ai Technologies Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zebra Medical Vision Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ContextVision AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imagen Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vuno Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxipit UAB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infervision Medical Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterys Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RadNet, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations